Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Avanos Medical (AVNS) Goodwill (2016 - 2025)

Avanos Medical's Goodwill history spans 11 years, with the latest figure at $794.4 million for Q2 2024.

  • For Q2 2024, Goodwill changed N/A year-over-year to $794.4 million; the TTM value through Jun 2024 reached $794.4 million, changed N/A, while the annual FY2023 figure was $796.1 million, 4.71% up from the prior year.
  • Goodwill for Q2 2024 was $794.4 million at Avanos Medical, roughly flat from $794.9 million in the prior quarter.
  • Across five years, Goodwill topped out at $826.0 million in Q1 2022 and bottomed at $742.5 million in Q4 2021.
  • The 5-year median for Goodwill is $796.1 million (2023), against an average of $793.5 million.
  • The largest annual shift saw Goodwill dropped 7.48% in 2021 before it grew 4.71% in 2023.
  • A 5-year view of Goodwill shows it stood at $802.5 million in 2020, then decreased by 7.48% to $742.5 million in 2021, then rose by 2.4% to $760.3 million in 2022, then increased by 4.71% to $796.1 million in 2023, then dropped by 0.21% to $794.4 million in 2024.
  • Per Business Quant, the three most recent readings for AVNS's Goodwill are $794.4 million (Q2 2024), $794.9 million (Q1 2024), and $796.1 million (Q4 2023).